Organisation paid for research Program year 2025 Source: CMS Open Payments

Adtremed Inc

Neither a doctor nor a teaching hospital

Research payments

$208,925

95 payments

Through program year 2025, Adtremed Inc is reported as receiving $208,925 in research payments, across 95 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$3,754	5
2024	Research	$153,986	83
2023	Research	$39,885	6
2022	Research	$11,300	1

Breakdown

Who paid Research payments · program years 2022–2025

Chiesi USA, Inc. $140,095 79 payments
Sanofi US Services Inc. $62,083 9 payments
Janssen Research & Development, LLC $6,746 7 payments

Studies the money was for Research payments · program years 2022–2025

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) $117,860 75 payments
Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) $33,133 6 payments
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (Triton) $22,235 4 payments
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Evaluate the Efficacy and Safety of Dupilumab Therapy in Patients With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype $15,700 1 payment
A Randomized, Double-blind, Placebo-controlled, 2-part Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Uncontrolled, Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP) $13,250 2 payments
A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial Fibrillation for Anticoagulant Treatment Outcomes $6,746 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.